Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
CIP is selling its Summerfield BESS project to Palisade. It is a 240 MW / 960 MWh 4-hour late-stage construction project near Adelaide in South Australia.
-
NEW YORK, April 08, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine...
-
Toowoomba, Australia, March 31, 2026 (GLOBE NEWSWIRE) -- DIT AgTech, a leader in precision livestock nutrition and delivery technology, has launched its Regulation Crowdfunding (Reg CF) investment...
-
SAN DIEGO, March 24, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic...
-
PharmAla provides an update on Cortexa, its Australian joint venture with Vitura Health.
-
NEW YORK and SYDNEY, March 19, 2026 (GLOBE NEWSWIRE) -- Tilray Medical, a recognized global leader in medical cannabis and a division of Tilray Brands, Inc. ("Tilray") (Nasdaq: TLRY; TSX: TLRY),...
-
Itron is extending its collaboration with Ausgrid to deploy Itron's IntelliFLEX to ensure grid reliability and compliance with market requirements.
-
Acquisition Includes BrewDog’s Profitable Australian Operations Including Brisbane Brewery and Two Flagship Bars Transaction Positions Tilray to Scale BrewDog Across Australia’s National Retail and...
-
NEW YORK, March 03, 2026 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine...
-
Durham, North Carolina, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Kevel, the leading retail media technology provider, today announced its steadfast commitment to the Asia-Pacific (APAC) region with its...